GLP-1 drugs may prevent deadly heart complications after heart attack
Fox News • • health
Key Points:
- A study published in Nature Communications reveals that GLP-1 weight-loss drugs may prevent life-threatening cardiac complications by opening tiny blood vessels blocked after a heart attack, a condition known as "no-reflow."
- Researchers from the University of Bristol and University College London identified a brain-gut-heart signaling pathway where GLP-1 activates potassium channels in pericytes, causing capillaries to widen and improve blood flow to heart tissue.
- The study, conducted on animal models and cellular imaging, showed that removing potassium channels negated the heart-protective effects of GLP-1 drugs, suggesting these medications could be repurposed for emergency heart attack treatments.
- Limitations include reliance on animal models and the need for clinical trials to confirm
